Bagán, A.; Rodriguez-Arévalo, S.; Taboada-Jara, T.; Griñán-Ferré, C.; Pallà s, M.; Brocos-Mosquera, I.; Callado, L.F.; Morales-GarcÃa, J.A.; Pérez, B.; Diaz, C.;
et al. Preclinical Evaluation of an Imidazole-Linked Heterocycle for Alzheimer’s Disease. Pharmaceutics 2023, 15, 2381.
https://doi.org/10.3390/pharmaceutics15102381
AMA Style
Bagán A, Rodriguez-Arévalo S, Taboada-Jara T, Griñán-Ferré C, Pallà s M, Brocos-Mosquera I, Callado LF, Morales-GarcÃa JA, Pérez B, Diaz C,
et al. Preclinical Evaluation of an Imidazole-Linked Heterocycle for Alzheimer’s Disease. Pharmaceutics. 2023; 15(10):2381.
https://doi.org/10.3390/pharmaceutics15102381
Chicago/Turabian Style
Bagán, Andrea, Sergio Rodriguez-Arévalo, Teresa Taboada-Jara, Christian Griñán-Ferré, Mercè Pallà s, Iria Brocos-Mosquera, Luis F. Callado, José A. Morales-GarcÃa, Belén Pérez, Caridad Diaz,
and et al. 2023. "Preclinical Evaluation of an Imidazole-Linked Heterocycle for Alzheimer’s Disease" Pharmaceutics 15, no. 10: 2381.
https://doi.org/10.3390/pharmaceutics15102381
APA Style
Bagán, A., Rodriguez-Arévalo, S., Taboada-Jara, T., Griñán-Ferré, C., Pallà s, M., Brocos-Mosquera, I., Callado, L. F., Morales-GarcÃa, J. A., Pérez, B., Diaz, C., Fernández-Godino, R., Genilloud, O., Beljkas, M., Oljacic, S., Nikolic, K., & Escolano, C.
(2023). Preclinical Evaluation of an Imidazole-Linked Heterocycle for Alzheimer’s Disease. Pharmaceutics, 15(10), 2381.
https://doi.org/10.3390/pharmaceutics15102381